UnknownPhase 2

Vitamin D Nasal Drops in Post COVID-19 Parosmia

Egypt60 participantsStarted 2022-06

Plain-language summary

The current study will be a pilot study for a randomized controlled trial conducted on patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia Faculty of Medicine To evaluate the effect of vitamin D nasal drops in the treatment of post COVID 19 parosmia

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

nclusion Criteria: * Patients should be more than 18 years old, * Patients having a history of COVID 19 infection more than three months ago as confirmed by PCR test, * Patients having a post COVID parosmia, * Patients having no history of systemic steroid administration over the last one month. Exclusion Criteria: * History of previous nasal surgery, * Underlying systemic diseases (like diabetes mellitus, hypertension, or autoimmune diseases), * Hypersensitivity to vitamin D3.

What they're measuring

Comparison between the pre and post treatment values

Timeframe: After one month of treatment

Comparison between case and control groups regarding the post treatment results

Timeframe: After one month of treatment

Trial details

NCT IDNCT05269017

SponsorMenoufia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03

Contact for this trial

Ahmad Hamdan, MD

00201008993175 Ahmed.Hamdan@med.menofia.edu.eg

View on ClinicalTrials.gov More Parosmia trials